Channeling studies in yeast: Yeast as a model for channelopathies?

NeuroMolecular Medicine

Volumn 8, Issue 3, 2006, Pages 279-306

  Wolfe, Devin M ^a   Pearce, David A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Channelopathies; Channels; Model systems; Saccharomyces cerevisiae

Indexed keywords

CALCIUM CHANNEL; CHLORIDE CHANNEL; GENE PRODUCT; ION CHANNEL; POTASSIUM CHANNEL; PROTEIN GEF1; SODIUM CHANNEL; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ATAXIA; CELL MEMBRANE; CHANNELOPATHY; FAMILIAL HEMIPLEGIC MIGRAINE; FUNGAL GENE; GENE MUTATION; GENERALIZED EPILEPSY; GENOME; GLYCOGEN STORAGE DISEASE TYPE 4; HOMEOSTASIS; HYPOKALEMIC PERIODIC PARALYSIS; ION TRANSPORT; MALIGNANT HYPERTHERMIA; MUCOLIPIDOSIS; MUCOLIPIDOSIS TYPE 4; MYOCLONUS EPILEPSY; MYOPATHY; NEUROLOGIC DISEASE; NIGHT BLINDNESS; NONHUMAN; PMC1 GENE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SACCHAROMYCES CEREVISIAE; SPINOCEREBELLAR DEGENERATION; YVC1 GENE;

ANIMALS; CALCIUM; CHANNELOPATHIES; HUMANS; ION CHANNELS; MUTATION; SACCHAROMYCES CEREVISIAE;

EUKARYOTA; PROKARYOTA; SACCHAROMYCES CEREVISIAE; SACCHAROMYCETALES;

EID: 33745232336     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:8:3:279     Document Type: Review

References (162)

1. Altschul S. F., Gish W., Miller E. W., and Lipman D. J. (1990) Basic local alignment search tool. J. Mol. Biol. 215(3), 403-410.
2. Amirlak I. and Dawson K. P. (2000) Bartter syndrome: an overview. QJM 93(4), 207-215.
3. Andermann F., Keene D. L., Andermann E., and Quesney L. F. (1980) Startle disease or hyperekplexia: further delineation of the syndrome. Brain 103(4), 985-997.
4. Ashcroft F. M. (2000) Ion Channels and Disease. London, Academic Press.
5. Balser J. R. (2001) The cardiac sodium channel: gating function and molecular pharmacology. J. Mol. Cell Cardiol. 33(4), 599-613.
6. Banuelos M. A., Sychrova H., Bleykasten-Grosshans C., Souciet J. L., and Potier S.(1998) The Nha1 antiporter of Saccharomyces cerevisiae mediates sodium and potassium efflux. Microbiology 144 (Part 10), 2749-2758.
7. Barrientos A. (2003) Yeast models of human mitochondrial diseases. IUBMB Life 55(2), 83-95.
8. Barry D. M. and Nerbonne J. M. (1996) Myocardial potassium channels: electrophysiological and molecular diversity. Annu. Rev. Physiol 58, 363-394.
9. Battistini S., Stenirri S., Piatti M., et al. (1999) A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology 53(1), 38-43.
10. Baulac S., Huberfeld G., Gourfinkel-An I., et al. (2001) First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma 2-subunit gene. Nat. Genet. 28(1), 46-48.
11. Bech-Hansen N. T., Boycott K. M., Gratton K. J., et al. (1998) Localization of a gene for incomplete X-linked congenital stationary night blindness to the interval between DXS6849 and DXS8023 in Xp11.23. Hum. Genet. 103(2), 124-130.
12. Berridge M. J. (1998) Neuronal calcium signaling. Neuron 21(1), 13-26.
13. Berridge M. J. (2002) The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium 32(5, 6), 235-249.
14. Berridge M. J., Bootman M. D., and Lipp P., (1998) Calcium - a life and death signal. Nature 395(6703), 645-648.
15. Bertl A., Ramos J., Ludwig J., et al. (2003) Characterization of potassium transport in wild-type and isogenic yeast strains carrying all combinations of trk1, trk2 and tok1 null mutations. Mol. Microbiol. 47(3), 767-780.
16. Biervert C., Schroeder B. C., Kubisch C., et al. (1998) A potassium channel mutation in neonatal human epilepsy. Science 279(5349), 403-406.
17. Bowers K., Levi B. P., Patel F. I., and Stevens T. H. (2000) he sodium/proton exchanger Nhx1p is required for endosomal protein trafficking in the yeast Saccharomyces cerevisiae. Mol. Biol. Cell 11(12), 4277-4294.
18. Bretschneider F., Wrisch A., Lehmanan-Horn F., and Grissmer S. (1999) Expression in mammalian cells and electrophysiological characterization of two mutant Kv1.1 channels causing episodic ataxia type 1 (EA-1). Eur. J. Neurosci. 11(7), 2403-2412.
19. Brody I. A. (1969) Muscle contracture induced by exercise. A syndrome attributable to decreased relaxing factor. N. Engl. J. Med. 281(4), 187-192.
20. Browne D. L., Gancher S. T., Nutt J. G., et al. (1994) Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat. Genet. 8(2), 136-140.
21. Caimi L., Tettamanti G., Berra B., et al. (1982) Mucolipidosis IV, a sialolipidosis due to ganglioside sialidase deficiency. J. Inherit. Metab. Dis. 5(4), 218-224.
22. Castaldo P., del Giudice E. M., Coppola G., Pascotto A., Annunziato L., and Taglialatela M. (2002) Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels. J. Neurosci. 22(2),RC199.
23. Catterall W. A. (1996) Molecular properties of sodium and calcium channels. J. Bioenerg. Biomembr. 28(3), 219-230.
24. Charlier C., Singh N. A., Ryan S. G., et al. (1998) Apore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat. Genet. 18(1), 53-55.
25. Chen C. S., Bach G., and Pagano R. E. (1998) Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc. Natl. Acad. Sci. USA 95(11), 6373-6378.
26. 2+) from reserve granules, lysosome-related organelles, in sea urchin eggs. Cell 111(5), 703-708.
27. Cossette P., Liu L., Brisebois K., et al. (2002) Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat. Genet. 31(2), 184-189.
28. Costanzo M. C., Hogan J. D., Cusick M. E., et al. (2000) "The yeast proteome database (YPD) amd Caenorhabditis elegans prteome database (WormPD): comprehensive resources for the organizaion and comparison of model organism protein information." Nucleic Acids Res. 28(1): 73-76.
29. 2+ ATPases. J. Cell Biol. 124(3), 351-363.
30. Curran M. E., Splawski I., Timothy K. W., Vincent G. M., Green E. D., and Keating M. T. (1995) A molecular basis for cardiac arrhythmia:HERG mutations cause long QT syndrome. Cell 80(5), 795-803.
31. D'Adamo M. C., Imbrici P., Sponcichetti F., and Pessia M. (1999) Mutations in the KCNA1 gene associated with episodic ataxia type-1 syndrome impair heteromeric voltage-gated K(+) channel function. FASEB J. 13(11), 1335-1345.
32. D'Adamo M. C., Liu Z., Adelman J. P., Maylie J., and Pessia M. (1998) Episodic ataxia type-1 mutations in the hKv1.1 cytoplasmic pore region alter the gating properties of the channel. EMBO J. 17(5), 1200-1207.
33. D'Agostino D., Bertelli M., Gallo S., et al. (2004) Mutations and polymorphisms of the CLCN2 gene in idiopathic epilepsy. Neurology 63(8), 1500-1502.
34. + pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33(2), 192-196.
35. De Waard M., Gurnett C.A., and Campbell K.P., (1996) Structural and functional diversity of voltage-activated calcium channels. Ion Channels 4, 41-87.
36. Denier C., Ducros A., Vahedi K., et al. (1999) High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2. Neurology 52(9), 1816-1821.
37. Dibbens L. M., Feng H. J., Richards M. C., et al. (2004) GABRD encoding a protein for extra- or perisynaptic GABAA receptors is a susceptibility locus for generalized epilepsies. Hum. Mol. Genet. 13(13), 1315-1319.
38. Duan D., Winter C., Cowley S., Hume J. R., and Horowitz B. (1997) Molecular identification of a volume-regulated chloride channel. Nature 390(6658), 417-421.
39. Ducros A., Denier C., Joutel A., et al. (2001) The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N. Engl. J. Med. 45(1), 17-24.
40. Dudel J. and S. W. Kuffler (1961) Presynaptic inhibition at the crayfish neuromuscular junction. J. Physiol. 155, 543-562.
41. Dutzler R. (2004) Structural basis for ion conduction and gating in ClC chloride channels. FEBS Lett. 564(3), 229-233.
42. Dutzler R., Campbell E. B., Cadene M., Chait B. T., and Mackinnon R. (2002) X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity. Nature 415(6869), 287-294.
43. Escayg A., Heils A., MacDonald B. T., Haug K., Sander T., and Meisler M. H. (2001) A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus - and prevalence of variants in patients with epilepsy. Am. J. Hum. Genet. 68(4), 866-873.
44. Escayg A., MacDonald B. T., Meisler M. H., et al. (2000) Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat. Genet. 24(4), 343-345.
45. Ezaki J., Wolfe L. S., and Kominami E. (1995) Defect of proteolysis of mitochondrial ATP synthase subunit C in neuronal ceroid lipofuscinosis. Gerontology 41 Suppl 2, 259-269.
46. Fahlke C., Beck C. L., and George A. L, Jr. (1997) A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel. Proc. Natl. Acad. Sci. USA 94(6), 2729-2734.
47. + channel in the budding yeast. J. Membr. Biol. 168(2), 149-157.
48. 2+ signaling networks in regulating gene expression by action potentials. Cell Calcium 37(5), 433-442.
49. Fischer M., Schnell N., Chattaway J., Davies P., Dixon G., and Sanders D. (1997) The Saccharomyces cerevisiae CCH1 gene is involved in calcium influx and mating. FEBS Lett. 419(23), 259-262.
50. Fleig A. and Penner R. (2004) The TRPM ion channel subfamily: molecular, biophysical and functional features. Trends Pharmacol. Sci. 25(12), 633-639.
51. Foury F. (1997) Human genetic diseases: a cross-talk between man and yeast. Gene 195(1), 1-10.
52. Fozzard H. A. and Hanck D. A. (1996) Structure and function of voltage-dependent sodium channels: comparison of brain II and cardiac isoforms. Physiol Rev. 76(3), 887-926.
53. Friend K. L., Crimmins D., Phan T. G., et al., (1999) Detection of a novel missense mutation and second recurrent mutation in the CACNA1A gene in individuals with EA-2 and FHM. Hum. Genet. 105(3), 261-265.
54. Gaber R. F., Styles C. A., Fink G. R. (1988) TRK1 encodes a plasma membrane protein required for high-affinity potassium transport in Saccharomyces cerevisiae. Mol. Cell Biol. 8(7), 2848-2859.
55. Gardiner M. (2005). Genetics of idiopathic generalized epilepsies. Epilepsia. 46(Suppl 9), 15-20.
56. + as evidences in single pancreatic islets. J. Biol. Chem. 268(30), 22,265-22,268.
57. Goebel H. H. (1995) The neuronal ceroid-lipofuscinoses. J. Child. Neurol. 10(6), 424-437.
58. Greene J. R., Brown N. H., DiDomenico B. J., Kaplan J. and Eide D. J (1993) The GEF1 gene of Saccharomyces cerevisiae encodes an integral membrane protein; mutations in which have effects on respiration and iron-limited growth. Mol. Gen. Genet. 241(56), 542-553.
59. Griggs R. C. and Nutt J. G. (1995) Episodic ataxias as channelopathies. Ann. Neurol. 37(3), 285-287.
60. Guida S., Trettel F., Pagnutti S., et al. (2001) Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am. J. Hum. Genet. 68(3), 759-764.
61. + channel beta subunit. Cell 97(7), 943-952.
62. Gunter T. E., Yule D. I., Gunter K. K., Eliseev R. A., and Salter J. D. (2004) Calcium and mitochondria. FEBS Lett. 567(1), 96-102.
63. Gunther W., Piwon N., and Jentsch T.J. (2003) The ClC-5 chloride channel knock-out mouse - an animal model for Dent's disease. Pflugers Arch. 445(4), 456-462.
64. Hans M., Luvisetto S., Williams M. E. (1999) Functional consequences of mutations in the human alphal A calcium channel subunit linked to familial hemiplegic migraine. J. Neurosci. 19(5), 1610-1619.
65. Hasenbrink G., Schwarzer S., Kolacna L., Ludwig J., Sychrova H., and Lichtenberg-Frate H.(2005) Analysis of the mKir2.1 channel activity in potassium influx defective Saccharomyces cerevisiae strains determined as changes in growth characteristics. FEBS Lett. 579(7), 1723-1731.
66. Haug K., Warnstedt M., Alekov A. K., et al. (2003) Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat. Genet. 33(4), 527-532.
67. Hille B. (2001) Ion Channels of excitable membranes. Sunderland, Mass, Sinauer.
68. Hirose S., Zenri F., Akiyoshi H., et al. (2000) A novel mutation of KCNQ3 (c.925T→C) in a Japanese family with benign familial neonatal convulsions. Ann. Neurol. 47(6), 822-826.
69. Hodges P. E., Carrico P. M., Hogan J. D., et al. (2002). Annotating the human proteome: the Human Proteome Survey Database (HumanPSD) and an indepth target database for G Protein-coupled receptors (GPCR-PD) from Incyte Genomics. Nucleic Acides Res. 30(1), 137-141.
70. Huang M. E., Chuat J. C., and Galibert F. (1994) A voltage-gated chloride channel in the yeast Saccharomyces cerevisiae. J. Mol. Biol. 242(4), 595-598.
71. 2+ influx and mating. Mol. Cell Biol. 14(12), 8259-8271.
72. Isope P. and Murphy T. H. (2005) Low threshold calcium currents in rat cerebellar Purkinje cell dendritic spines are mediated by T-type calcium channels. J. Physiol. 562(Pt 1), 257-269.
73. Jentsch T. J., Friedrich T., Schriever A., and Yamada H. (1999) The CLC chloride channel family. Pflugers Arch. 437(6), 783-795.
74. Jentsch T. J., Gunther W., Pusch M., and Schwappach B. (1995) Properties of voltage-gated chloride channels of the ClC gene family. J. Physiol. 482, 19S-25S.
75. Jentsch T. J., Maritzen T., and Zdebik A. A. (2005) Chloride channel diseases resulting from impaired transepithelial transport or vesicular function. J. Clin. Invest. 115(8), 2039-2046.
76. + channel. Nature 423(6935), 33-41.
77. Jodice C., Mantuano E., Veneziano L., et al. (1997) Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum. Mol. Genet. 6(11), 1973-1978.
78. Jongsma H. J. and Wilders R. (2001) Channelopathies: Kir2.1 mutations jeopardize many cell functions. Curr. Biol. 11(18), R747-750.
79. Joutel A., Bousser M. G., Biousse V., et al. (1993) A gene for familial hemiplegic migraine maps to chromosome 19. Nat. Genet. 5(1), 40-45.
80. Jurkat-Rott K., Lehmann-Horn F., Elbaz A., et al. (1994) A calcium channel mutation causing hypokalemic periodic paralysis. Hum. Mol. Genet. 3(8), 1415-1419.
81. Jurkat-Rott K., Mitrovic N., Hang C. et al. (2000) Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc. Natl. Acad. Sci. USA 97(17), 9549-9554.
82. Ketchum K. A., Joiner W. J., Sellers A. J., Kaczmarek L. K. and Goldstein S. A. (1995) A new family of outwardly rectifying potassium channel proteins with two pore domains in tandem. Nature 376(6542), 690-695.
83. Kida Y., Uchida S., Miyazaki H., Sasaki S., and Marumo F. (2001) Localization of mouse CLC-6 and CLC-7 mRNA and their functional complementation of yeast CLC gene mutant. Histochem. Cell Biol. 115(3), 189-194.
84. + transport in Saccharomyces cerevisiae. Genetics 125(2), 305-312.
85. + transporters in Saccharomyces cerevisiae. Mol. Cell Biol. 11(8), 4266-4273.
86. Koch M. C., Steinmeyer K., Lorenz C., et al. (1992). The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 257(5071), 797-800.
87. Kornak U., Kasper D., Bosl M. R., et al. (2001) Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104(2), 205-215.
88. Kors E. E., van den Maagdenberg A. M., Plomp J. J., Frants R. R., and Ferrari M. D., (2002). Calcium channel mutations and migraine. Curr. Opin. Neurol. 15(3), 311-316.
89. Kors E. E., Vanmolkot K. R., Haan J., Frants R. R., van den Maagdenberg A. M., Ferrari M. D. (2004). Recent findings in headache genetics. Curr. Opin. Neurol. 17(3), 283-288.
90. + channel kinetics. J. Biol. Chem. 273(10), 5586-5590.
91. Kullmann D. M. (2002) The neuronal channelopathies. Brain 125(Part 6), 1177-1195.
92. Kullmann D. M., Rea R., Spavschus A., and Jouvenceau A. (2001) The inherited episodic ataxias: how well do we understand the disease mechanisms? Neuroscientist 7(1), 80-88.
93. Lacinova L. (2005) Voltage-dependent calcium channels. Gen. Physiol. Biophys. 24(Suppl 1), 1-78.
94. Lanini L., Bachs O., and Carafoli E. (1992) The calcium pump of the liver nuclear membrane is identical to that of endoplasmic reticulum. J. Biol. Chem. 267(16) 11,548-11,552.
95. Leppert M. and Singh N. (1999) Benign familial neonatal epilepsy with mutations in two potassium channel genes. Curr. Opin. Neurol. 12(2), 143-147.
96. Lerche H., Weber Y. G., Jurkat-Rott K., and Lehmann-Horn F. (2005) Ion channel defects in idiopathic epilepsies. Curr. Pharm. Des. 11(21), 2737-2752.
97. + current due to a novel mutation in KCNQ2 causes neonatal convulsions. Ann. Neurol. 46(3), 305-312.
98. Litt M., Kramer P., Browne D., et al. (1994) A gene for episodic ataxia/myokymia maps to chromosome 12p13. Am. J. Hum. Genet. 55(4), 702-709.
99. Lloyd S. E., Pearce S. H., Fisher S. E., et al. (1996) A common molecular basis for three inherited kidney stone diseases. Nature 379(6564), 445-449.
100. Locke E. G., Bonilla M., Liang L., Takita Y., and Cunningham K. W. (2000) A homolog of voltage-gated Ca(2+) channels stimulated by depletion of secretory Ca(2+) in yeast. Mol. Cell. Biol. 20(18), 6686-6694.
101. Lopes C. M., Zhang H., Rohacs T., Jin T., Yang J., and Logothetis D. E., (2002) Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies. Neuron 34(6), 933-944.
102. + channels. J. Gen. Physiol. 125(6), 521-527.
103. Mackenzie L., Bootman M. D., Laine M., et al. (2002) The role of inositol 1,4,5-trisphosphate receptors in Ca(2+) signalling and the generation of arrhythmias in rat atrial myocytes. J. Physiol. 541(Pt 2), 395-409.
104. Madrid R., Gomez M. J., Ramos J., and Rodriguez-Navarro A. (1998) Ectopic potassium uptake in trkl trk2 mutants of Saccharomyces cerevisiae correlates with a highly hyperpolarized membrane potential. J. Biol. Chem. 273(24), 14,838-14,844.
105. Malathi K., Higaki K., Tinkelenberg A. H., et al. (2004) Mutagenesis of the putative sterol-sensing domain of yeast Niemann Pick C-related protein reveals a primordial role in subcellular sphingolipid distribution. J. Cell Biol. 164(4), 547-556.
106. 2+ transient activates calcineurin signaling to mediate ion homeostasis and salt tolerance of Saccharomyces cerevisiae. J. Biol. Chem. 277(36), 33,075-33,080.
107. 2+ channel property by polyglutamine expansion in spinocerebellar ataxia 6. J. Neurosci. 19(12), RC14.
108. May A., Ophoff R. A., Terwindt G. M., et al. (1995) Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum. Genet. 96(5), 604-648.
109. McCusker J. H., Perlin D. S., and Haber J. E. (1987) Pleiotropic plasma membrane ATPase mutations of Saccharomyces cerevisiae. Mol. Cell Biol. 7(11), 4082-4088.
110. Merin S., Livni N., Berman E. R., and Yatziv S. (1975). Mucolipidosis IV: ocular, systemic, and ultrastructural findings. Invest. Ophthalmol. 14(6), 437-448.
111. Metz A. E., Jarsky T., et al. (2005) R-type calcium channels contribute to afterdepolarization and bursting in hippocampal CA1 pyramidal neurons. J. Neurosci. 25(24), 5763-5773.
112. Mohammad-Panah, R., Harrison R., Dhani S., et al. (2003) The chloride channel ClC-4 contributes to endosomal acidification and trafficking. J. Biol. Chem. 278(31), 29,267-29,277.
113. Monnier N., Procaccio V., Stieglitz P. and Lunardi J. (1997) Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridinesensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am. J. Hum. Genet. 60(6), 1316-1325.
114. Mulley J. C., Scheffer I. E., Petrou S., and Berkovic S. F. (2003) Channelopathies as a genetic cause of epilepsy. Curr. Opin. Neurol. 16(2), 171-176.
115. Nilius, B., Eggermont J., Voets T., and Droogmans G. (1996) Volume-activated C1- channels. Gen. Pharmacol. 27(7), 1131-1140.
116. 2+ ATPase, areassociated with Brody disease. Nat. Genet. 14(2), 191-194.
117. 2+ channel gene CACNL1A4. Cell 87(3), 543-552.
118. Outeiro T. F. and Muchowski P. J. (2004) Molecular genetics approaches in yeast to study amyloid diseases. J. Mol. Neurosci. 23(1, 2), 49-60.
119. 2+ uptake and exacerbates the cdc1(Ts) growth defect. Mol. Cell Biol. 17(11), 6339-6347.
120. Palmer C. P., Zhou X. L., Lin J., Loukin S. H., Kung C., Saimi Y. (2001) A TRP homolog in Saccharomyces cerevisiae forms an intracellular Ca(2+)-permeable channel in the yeast vacuolar membrane. Proc. Natl. Acad. Sci. USA 98(14), 7801-7805.
121. Pearce D. A. and Sherman F. (1998) A yeast model for the study of Batten disease. Proc. Natl. Acad. Sci. USA 95(12), 6915-6918.
122. Perlin D. S., Brown C. L., and Haber J. E. (1988) Membrane potential defect in hygromycin Bresistant pmal mutants of Saccharomyces cerevisiae. J. Biol. Chem. 263(34), 18,118-18,122.
123. 2+ store, with functional properties distinct from those of the endoplasmic reticulum. EMBO J. 17(18), 5298-5308.
124. Plaster N. M., Tawil R., Tristani-Firouzi M., et al. (2001) Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105(4), 511-519.
125. Quane K. A., Healy J. M., Keating K. E., et al. (1993) Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat. Genet. 5(1), 51-55.
126. Ramirez J. M., Tryba A. K., and Pena F. (2004) Pacemaker neurons and neuronal networks:an integrative view. Curr. Opin. Neurobiol. 14(6), 665-674.
127. Ramos J., Alijo R., Haro R., and Rodriguez-Navarro A. (1994). TRK2 is not a low-affinity potassium transporter in Saccharomyces cerevisiae. J. Bacteriol. 176(1), 249-252.
128. Restituito S., Thompson R. M., Eliet J., et al. (2000) The polyglutamine expansion in spinocerebellar ataxia type 6 causes a beta subunit-specific enhanced activation of P/Q-type calcium channels in Xenopus oocytes. J. Neurosci. 20(17), 6394-6403.
129. + channels and the molecular pathogenesis of epilepsy: implications for therapy. Trends Neurosci. 23(9), 393-398.
130. Saimi Y., Martinac B., Delcour A. H., et al. (1992) Patch clamp studies of microbial ion channels. Methods Enzymol. 207, 681-691.
131. Saimi Y., Martinac B., Gustin M. C., Culbertson M. R., Adler J., and Kung C. (1988) Ion channels in Paramecium, yeast, and Escherichia coli. Trends Biochem. Sci. 13(8), 304-309.
132. Scheffer I. E. and Berkovic S. F. (1997) Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 120(Part 3), 479-490.
133. Schiestl R. H. and Gietz R. D. (1989) High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet. 16(56), 339-346.
134. Serrano R. (1996) Salt tolerance in plants and microorganisms: toxicity targets and defense responses. Int. Rev. Cytol. 165, 1-52.
135. Singh N. A., Charlier C., Stauffer D., et al. (1998) A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat. Genet. 18(1), 25-29.
136. Somjen G. (2004) Ions in the Brain:Normal Function, Seizures, and Stroke. New York, Oxford University Press.
137. Spampanato J., Escayg A., Meisler M. H., and Goldin A. L. (2001) Functional effects of two voltage-gated sodium channel mutations that cause generalized epilepsy with febrile seizures plus type 2. J. Neurosci. 21(19), 7481-7490.
138. Spampanato J., Escayg A., Meisler M. H., and Goldin A. L. (2003) Generalized epilepsy with febrile seizures plus type 2 mutation W1204R alters voltage-dependent gating of Na(v)1.1 sodium channels. Neuroscience 116(1), 37-48.
139. Spampanato J., Kearney J. A., de Haart G., et al. (2004) A novel epilepsy mutation in the sodium channel SCN1A identifies a cytoplasmic domain for beta subunit interaction. J. Neurosci. 24(44), 10,022-10,034.
140. Steinlein O. K. (2002) Channelopathies can cause epilepsy in man. Eur. J. Pain 6(Suppl A), 27-34.
141. Stern M. D., Pizarro G., and Rios E. (1997) Local control model of excitation-contraction coupling in skeletal muscle. J. Gen. Physiol. 110(4), 415-440.
142. 2+ channelopathies. Biochem. Biophys. Res. Commun. 322(4), 1341-1346.
143. 2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit. Proc. Natl. Acad. Sci. USA 88(23), 10,769-10,773.
144. + channels. Curr. Opin. Neurobiol. 2(3), 243-246.
145. Tasaka Y., Nakagawa Y., Sato C., et al. (2000) yam8(+), a Schizosaccharomyces pombe gene, is a potential homologue of the Saccharomyces cerevisiae MID1 gene encoding a stretch-activated Ca(2+)-permeable channel. Biochem. Biophys. Res. Commun. 269(1), 265-269.
146. Terwindt G. M., Ophoff R. A., Haan J., Sandkuijl L. A., Frants R. R., and Ferrari M. D. (1998) Migraine, ataxia and epilepsy: a challenging spectrum of genetically determined calcium channelopathies. Dutch Migraine Genetics Research Group. Eur. J. Hum. Genet. 6(4), 297-307.
147. Turnbull J., Lohi H., Kearney J. A., et al. (2005). Sacred disease secrets revealed: the genetics of human epilepsy. Hum. Mol. Genet. 14(17), 2491-2500.
148. +-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann. Neurol. 54(3), 360-366.
149. Viswanathan P. C. and Balser J. R. (2004) Inherited sodium channelopathies: a continuum of channel dysfunction. Trends Cardiovasc. Med. 14(1), 28-35.
150. +-channel betal subunit gene SCN1B. Nat. Genet. 19(4), 366-370.
151. Wang Q., Shen J., Splawski I., et al. (1995) SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80(5), 805-811.
152. Weimer J. M., Kriscenski-Perry E., Elshatory Y., and Pearce D. A. (2002) The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease. Neuromolecular Med. 1(2), 111-124.
153. Wells L. and Fridovich-Keil J. L. (1996) The yeast, Saccharomyces cerevisiae, as a model system for the study of human genetic disease. SAAS Bull Biochem. Biotechnol. 9, 83-88.
154. Weylandt K. H., Valverde M. A., Nobles M., et al. (2001) Human ClC-3 is not the swelling activated chloride channel involved in cell volume regulation. J. Biol. Chem. 276(20), 17,461-17,467.
155. Wu L. G., Westenbroek R. E., Borst J. G., Catterall W. A., and Sakmann B. (1999) Calcium channel types with distinct presynaptic localization couple differentially to transmitter release in single calyxtype synapses. J. Neurosci. 19(2), 726-736.
156. Yoshikawa M., Uchida S., Ezaki J., et al. (2002) CLC-3 deficiency leads to phenotypes similar to human neuronal ceroid lipofuscinosis. Genes Cells 7(6), 597-605.
157. 2+ channel component Midl. Exp. Cell Res. 293(2), 185-195.
158. Yue Q., Jen J. C., Nelson S. F., and Baloh R. W. (1997) Progressive ataxia due to a missense mutation in a calcium-channel gene. Am. J. Hum. Genet. 61(5), 1078-1087.
159. Yunker A. M. and McEnery M. W. (2003) Low-voltage-activated (T-Type) calcium channels in review. J. Bioenerg. Biomembr. 35(6), 533-575.
160. Zhou L., Chillag K. L., and Nigro M. A. (2002) Hyperekplexia: a treatable neurogenetic disease. Brain Dev. 24(7), 669-674.
161. Zhuchenko O., Bailey J, Bonnen P., et al. (1997) Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage dependent calcium channel. Nat. Genet. 15(1), 62-69.
162. Zuberi, S. M., Eunson L. H., Spauschus A., et al. (1999) A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 122(Part 5), 817-825.